Vontobel Holding Ltd. Has $4.46 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Vontobel Holding Ltd. cut its holdings in shares of CVS Health Co. (NYSE:CVS) by 14.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 99,324 shares of the pharmacy operator’s stock after selling 16,590 shares during the period. Vontobel Holding Ltd.’s holdings in CVS Health were worth $4,459,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. MidAtlantic Capital Management Inc. boosted its position in CVS Health by 112.1% during the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator’s stock worth $37,000 after buying an additional 437 shares during the period. Aljian Capital Management LLC boosted its position in CVS Health by 21.0% during the 4th quarter. Aljian Capital Management LLC now owns 13,349 shares of the pharmacy operator’s stock worth $599,000 after buying an additional 2,319 shares during the period. Stanley Laman Group Ltd. boosted its position in CVS Health by 1,366.8% during the 4th quarter. Stanley Laman Group Ltd. now owns 80,672 shares of the pharmacy operator’s stock worth $3,621,000 after buying an additional 75,172 shares during the period. Van ECK Associates Corp raised its holdings in CVS Health by 24.8% during the 4th quarter. Van ECK Associates Corp now owns 644,326 shares of the pharmacy operator’s stock worth $28,924,000 after purchasing an additional 128,231 shares during the last quarter. Finally, Legato Capital Management LLC raised its holdings in CVS Health by 9.7% during the 4th quarter. Legato Capital Management LLC now owns 27,914 shares of the pharmacy operator’s stock worth $1,253,000 after purchasing an additional 2,470 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Price Performance

CVS opened at $65.71 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company has a market capitalization of $82.68 billion, a price-to-earnings ratio of 16.68, a P/E/G ratio of 0.60 and a beta of 0.61. The firm’s fifty day moving average price is $51.11 and its two-hundred day moving average price is $56.08. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, analysts anticipate that CVS Health Co. will post 5.14 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.05%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio is 67.51%.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Leerink Partners upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $55.00 to $75.00 in a report on Thursday. Piper Sandler lowered their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday, November 25th. Leerink Partnrs upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday. Wolfe Research raised their price target on shares of CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a report on Tuesday, February 11th. Finally, Mizuho lowered their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average price target of $70.28.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.